ID   HRT-18G
AC   CVCL_2515
DR   CLO; CLO_0003837
DR   ATCC; CRL-11663
DR   cancercelllines; CVCL_2515
DR   Wikidata; Q54895338
RX   Patent=US5580778;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11663.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
ST   Source(s): ATCC
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2514 ! HRT-18
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
RX   Patent=US5580778;
RA   Storz J.;
RT   "Isolation and diagnosis of coronaviruses as a factor in bovine
RT   shipping fever, and a cell line for culturing both those and other
RT   bovine coronaviruses.";
RL   Patent number US5580778, 03-Dec-1996.
//